Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Go back to Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Tandem Diabetes (TNDM) Tops Q2 EPS by 14c

August 4, 2021 5:05 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of $0.06, $0.14 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $172.1 million versus the consensus estimate of $143.63 million.

GUIDANCE:

Tandem Diabetes sees FY2021 revenue of $670-685 million, versus the consensus... More